Similar articles

• Retracted: Identification and Validation of Potential Biomarkers and Pathways for Idiopathic Pulmonary Fibrosis by Comprehensive Bioinformatics Analysis.

  International BR. International BR. Biomed Res Int. 2024 Mar 20;2024:9848271. doi: 10.1155/2024/9848271. eCollection 2024. Biomed Res Int. 2024. PMID: 38550096 Free PMC article.
• The effect of statin therapy on disease-related outcomes in idiopathic pulmonary fibrosis: A systematic review and meta-analysis.

  Kim JW, Barrett K, Loke Y, Wilson AM. Kim JW, et al. Respir Med Res. 2021 Nov;80:100792. doi: 10.1016/j.resmer.2020.100792. Epub 2020 Oct 2. Respir Med Res. 2021. PMID: 34091200
• Retracted: m6A RNA Methylation Regulators Contribute to Predict and as a Therapy Target of Pulmonary Fibrosis.

  And Alternative Medicine EC. And Alternative Medicine EC. Evid Based Complement Alternat Med. 2023 Dec 6;2023:9890723. doi: 10.1155/2023/9890723. eCollection 2023. Evid Based Complement Alternat Med. 2023. PMID: 38093871 Free PMC article.
• Retracted: The Effects of Statin Therapy on Oxidized LDL and Its Antibodies: A Systematic Review and Meta-Analysis.

  Longevity OMAC. Longevity OMAC. Oxid Med Cell Longev. 2024 Jan 9;2024:9849024. doi: 10.1155/2024/9849024. eCollection 2024. Oxid Med Cell Longev. 2024. PMID: 38234524 Free PMC article.
• Progress of Statin Therapy in the Treatment of Idiopathic Pulmonary Fibrosis.

  Kou L, Kou P, Luo G, Wei S. Kou L, et al. Oxid Med Cell Longev. 2022 Mar 19;2022:6197219. doi: 10.1155/2022/6197219. eCollection 2022. Oxid Med Cell Longev. 2022. Retraction in: Oxid Med Cell Longev. 2024 Jan 9;2024:9830469. doi: 10.1155/2024/9830469 PMID: 35345828 Free PMC article. Retracted. Review.